Skip to content

Clinical trials

Phase 2 Esophageal Squamous Cell Carcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Squamous Cell Carcinoma Phase: Phase 2 Country / region: United States Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20013
20022
20032
20042
20054
20065
20081
20103
20111
20121
20131
20161
20172
20181
20192
20212
20221
20231
20243
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated9
Recruiting5
Active, not recruiting3
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center7
City of Hope Medical Center4
Alliance for Clinical Trials in Oncology3
National Cancer Institute (NCI)3
Roswell Park Cancer Institute3
Case Comprehensive Cancer Center2
Dana-Farber Cancer Institute2
Fox Chase Cancer Center2
Radiation Therapy Oncology Group2
SWOG Cancer Research Network2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Squamous Cell Carcinoma51
Esophageal Neoplasms37
Stomach Neoplasms10
Squamous Cell Carcinoma of Head and Neck6
Carcinoma, Squamous Cell4
Carcinoma, Non-Small-Cell Lung3
Adenocarcinoma2
Carcinoma, Hepatocellular2
Colorectal Neoplasms2
Head and Neck Neoplasms2

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.